Impact of Oral Ovulatory Induction Medications Among Female Military Members and Military Beneficiaries.

Introduction: Twelve percent of reproductive aged females in the United States have utilized fertility services, and it is estimated that 25% of infertility patients have ovulatory dysfunction. Clomiphene and letrozole are currently first-line treatment options for ovulatory dysfunction. These are both disqualifying medications in the U.